Together we will find a cure Donate
Together we will find a cure Donate


National brain tumour research funding needs to increase to £35 million a year

Poliovirus, Car -T, Proton Beam and seaweed

  • Two clinical trials are underway to assess the effectiveness of a type of cell-based therapy called CAR T-cells in tackling diffuse intrinsic pontine glioma (DIPG), and another related disease with a similarly poor prognosis, diffuse midline glioma (DMG). Both trials are using the genetically engineered cells, most often made by taking a patient’s own T-cells and genetically manipulating them to hone in on a specific target present on cancer cells and attack them. When reporting on her findings leader of the clinical trial at Stanford University Michelle Monje, MD, PhD, says “It was a striking and consistent result; after more than a decade of research in DIPG preclinical models, I had never seen anything that promising.”
  • If you two minutes to spare this weekend watch this video clip about how “Gammatiles zap brain cancer” – essentially after a tumour is removed, a gamma tile is left in place to attack any newly growing cells within its vicinity.

Related reading:

If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.

Donate today

Help us build the UK's largest network of experts in sustainable brain tumour research and campaign for more investment nationally. Together we will find a cure.